Zurich Cantonal Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.51M Buy
30,733
+1,406
+5% +$276K 0.01% 614
2026
Q1
$5.75M Sell
29,327
-51,452
-64% -$10M 0.01% 616
2025
Q4
$14M Buy
80,779
+44,780
+124% +$8.15M 0.03% 422
2025
Q3
$6.86M Buy
35,999
+3,121
+9% +$554K 0.02% 536
2025
Q2
$5.91M Sell
32,878
-22,177
-40% -$3.85M 0.01% 552
2025
Q1
$9.32M Sell
55,055
-2,627
-5% -$432K 0.03% 464
2024
Q4
$8.7M Sell
57,682
-56,321
-49% -$8.76M 0.02% 465
2024
Q3
$17.7M Buy
114,003
+6,839
+6% +$1.02M 0.05% 314
2024
Q2
$14.7M Buy
107,164
+23,618
+28% +$3.23M 0.05% 336
2024
Q1
$11.1M Buy
83,546
+9,541
+13% +$1.24M 0.04% 373
2023
Q4
$10.2M Sell
74,005
-73,036
-50% -$9.6M 0.04% 384
2023
Q3
$17.9M Buy
147,041
+32,158
+28% +$4.28M 0.08% 222
2023
Q2
$16.1M Buy
114,883
+63,122
+122% +$8.7M 0.07% 241
2023
Q1
$7.32M Buy
51,761
+1,844
+4% +$264K 0.04% 405
2022
Q4
$7.81M Buy
49,917
+16,056
+47% +$2.31M 0.04% 387
2022
Q3
$4.15M Sell
33,861
-1,483
-4% -$195K 0.02% 510
2022
Q2
$4.7M Sell
35,344
-54,392
-61% -$7.41M 0.03% 480
2022
Q1
$12.3M Sell
89,736
-15,406
-15% -$2.15M 0.06% 300
2021
Q4
$18.2M Buy
105,142
+9,105
+9% +$1.39M 0.09% 213
2021
Q3
$14M Buy
96,037
+23,283
+32% +$3.41M 0.08% 244
2021
Q2
$9.6M Buy
72,754
+7,268
+11% +$952K 0.05% 334
2021
Q1
$8.4M Sell
65,486
-17,327
-21% -$2.14M 0.05% 351
2020
Q4
$9.87M Buy
82,813
+37,183
+81% +$4.53M 0.06% 308
2020
Q3
$5.22M Buy
45,630
+16,122
+55% +$1.9M 0.04% 420
2020
Q2
$3.36M Sell
29,508
-59,911
-67% -$6.35M 0.03% 490
2020
Q1
$7.18M Sell
89,419
-189
-0.2% -$19.6K 0.07% 286
2019
Q4
$9.57M Buy
89,608
+2,237
+3% +$233K 0.07% 289
2019
Q3
$9.35M Buy
87,371
+30,299
+53% +$3.11M 0.08% 280
2019
Q2
$5.81M Buy
57,072
+21,221
+59% +$2.04M 0.05% 390
2019
Q1
$3.22M Sell
35,851
-6,555
-15% -$568K 0.03% 505
2018
Q4
$3.53M Sell
42,406
-89,879
-68% -$8.43M 0.04% 458
2018
Q3
$14.3M Sell
132,285
-224
-0.2% -$24.6K 0.12% 201
2018
Q2
$14.6M Sell
132,509
-3,998
-3% -$416K 0.13% 181
2018
Q1
$13.7M Buy
136,507
+28,514
+26% +$2.92M 0.12% 204
2017
Q4
$10.6M Sell
107,993
-13,061
-11% -$1.24M 0.09% 254
2017
Q3
$11.3M Buy
121,054
+27,467
+29% +$2.92M 0.11% 226
2017
Q2
$10.4M Sell
93,587
-4,345
-4% -$459K 0.1% 228
2017
Q1
$9.62M Buy
97,932
+1,569
+2% +$150K 0.09% 240
2016
Q4
$8.86M Sell
96,363
-5,268
-5% -$454K 0.09% 235
2016
Q3
$8.6M Buy
101,631
+18,016
+22% +$1.51M 0.09% 244
2016
Q2
$6.81M Buy
83,615
+68,103
+439% +$5.19M 0.09% 248
2016
Q1
$1.11M Buy
15,512
+3,432
+28% +$230K 0.01% 687
2015
Q4
$859K Sell
12,080
-2,447
-17% -$165K 0.01% 732
2015
Q3
$893K Buy
14,527
+1,120
+8% +$78.3K 0.01% 721
2015
Q2
$972K Hold
13,407
0.01% 722
2015
Q1
$1.03M Sell
13,407
-936
-7% -$67K 0.01% 687
2014
Q4
$962K Buy
14,343
+3,000
+26% +$189K 0.03% 543
2014
Q3
$688K Hold
11,343
0.02% 618
2014
Q2
$666K Sell
11,343
-51,483
-82% -$3.01M 0.02% 657
2014
Q1
$3.64M Buy
62,826
+11,784
+23% +$632K 0.11% 202
2013
Q4
$2.73M Buy
51,042
+22,276
+77% +$1.32M 0.09% 255
2013
Q3
$1.78M Buy
28,766
+20,911
+266% +$1.25M 0.06% 328
2013
Q2
$476K Buy
+7,855
New +$468K 0.02% 584

Other funds holding DGX

Zurich Cantonal Bank's DGX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Quest Diagnostics (DGX) stake by 4.8% in Q2 2026, buying an estimated $276K and bringing the position to 30,733 shares worth $6.51M. The position accounts for 0.01% of the portfolio, ranked #614.

Zurich Cantonal Bank first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.2M in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Zurich Cantonal Bank held 30,733 shares of Quest Diagnostics worth $6.51M as of Q2 2026.
  • Zurich Cantonal Bank bought 1,406 Quest Diagnostics shares in Q2 2026, an estimated $276K.
  • Quest Diagnostics made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #614 holding.
  • Zurich Cantonal Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Zurich Cantonal Bank's Quest Diagnostics position peaked at $18.2M in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.